Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,241 | 760 | 88.7% |
| Travel and Lodging | $1,461 | 8 | 9.8% |
| Education | $161.93 | 8 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61.34 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,410 | 211 | $0 (2024) |
| Medtronic, Inc. | $1,753 | 19 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $899.94 | 32 | $0 (2024) |
| GENZYME CORPORATION | $663.69 | 26 | $0 (2023) |
| Eisai Inc. | $593.62 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $564.01 | 30 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $553.01 | 32 | $0 (2024) |
| Neurelis, Inc. | $529.34 | 33 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $526.92 | 20 | $0 (2024) |
| UCB, Inc. | $504.69 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,669 | 193 | ABBVIE INC. ($469.53) |
| 2023 | $3,461 | 194 | ABBVIE INC. ($633.20) |
| 2022 | $4,834 | 198 | Medtronic, Inc. ($1,705) |
| 2021 | $2,962 | 195 | AbbVie Inc. ($498.75) |
All Payment Transactions
780 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Neurology | ||||||
| 12/01/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: EPILEPSY | ||||||
| 11/26/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology and Neurology | ||||||
| 11/25/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $61.96 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: EPILEPSY | ||||||
| 11/07/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 579 | 961 | $249,950 | $63,565 |
| 2022 | 4 | 691 | 1,150 | $150,060 | $81,879 |
| 2021 | 4 | 732 | 1,225 | $158,965 | $93,373 |
| 2020 | 3 | 776 | 1,258 | $160,190 | $78,127 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 259 | 475 | $131,150 | $34,134 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 194 | 360 | $74,400 | $17,558 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 126 | 126 | $44,400 | $11,872 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 307 | 528 | $66,000 | $41,271 | 62.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 241 | 479 | $43,110 | $25,864 | 60.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 130 | 130 | $39,000 | $13,319 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $1,950 | $1,426 | 73.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 320 | 575 | $71,875 | $48,300 | 67.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 268 | 506 | $45,540 | $29,156 | 64.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 133 | 133 | $39,900 | $14,597 | 36.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $1,650 | $1,320 | 80.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 368 | 652 | $81,500 | $43,862 | 53.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 293 | 491 | $44,190 | $22,295 | 50.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 115 | 115 | $34,500 | $11,970 | 34.7% |
About Doris Yoder, NP
Doris Yoder, NP is a Family healthcare provider based in Yuma, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1730668328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Doris Yoder, NP has received a total of $14,926 in payments from pharmaceutical and medical device companies, with $3,669 received in 2024. These payments were reported across 780 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,241).
As a Medicare-enrolled provider, Yoder has provided services to 2,778 Medicare beneficiaries, totaling 4,594 services with total Medicare billing of $316,944. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Yuma, AZ
- Active Since 08/14/2018
- Last Updated 08/14/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730668328
Products in Payments
- PERCEPT PC BRAINSENSE (Device) $1,665
- UBRELVY (Drug) $864.87
- INGREZZA (Drug) $825.36
- QULIPTA (Drug) $702.03
- AUBAGIO (Drug) $663.69
- BOTOX (Biological) $545.86
- VALTOCO (Drug) $529.34
- KESIMPTA (Drug) $480.10
- ULTOMIRIS (Biological) $419.97
- Leqembi (Drug) $391.53
- AUSTEDO (Drug) $353.84
- VRAYLAR (Drug) $348.76
- APTIOM (Drug) $279.60
- NURTEC ODT (Drug) $261.84
- BAFIERTAM (Drug) $260.86
- CAPLYTA (Drug) $249.72
- FYCOMPA (Drug) $235.30
- Fycompa (Drug) $202.09
- EMGALITY (Drug) $197.49
- SPRAVATO (Drug) $189.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Yuma
William Holder, Fnp-C, FNP-C
Family — Payments: $3,812
Mandy Moreno, Fnp, FNP
Family — Payments: $3,535
Ms. Maria Nunez, Cnp, CNP
Family — Payments: $3,324
Kiran Dhillon
Family — Payments: $3,299
Ms. Pauline Dell, Fnp-C, FNP-C
Family — Payments: $3,188
Margery Smith, Fnp-C, FNP-C
Family — Payments: $3,088